Adverse prognostic impact of KIT exon 17 mutations despite negative flow cytometric measurable residual disease in pediatric acute myeloid leukemia with RUNX1::RUNX1T1

Affiliations

• ¹ Department of Pediatrics, Graduate School of Medicine, the University of Tokyo, Tokyo.
• ² Department of Pediatrics, Yokohama City University Graduate School of Medicine, Yokohama.
• ³ Center for Clinical Research and Advanced Medicine, Shiga University of Medical Science, Otsu.
• ⁴ Department of Pediatrics, Graduate School of Medicine Mie University, Tsu.
• ⁵ Department of Pediatrics, Graduate School of Medicine Kyoto University, Kyoto.
• ⁶ Department of Virology, Nagoya City University Graduate School of Medical Sciences, Nagoya.
• ⁷ Department of Pediatric Hematology and Oncology Research, National Research Institute for Child Health and Development, Tokyo.
• ⁸ Division of Cancer Immunodiagnostics, Children's Cancer Center, National Center for Child Health and Development, Tokyo.
• ⁹ Department of Clinical Biostatistics, Graduate School of Medicine, Kyoto University, Kyoto.
• ¹⁰ Human Health Science, Graduate School of Medicine Kyoto University, Kyoto, Japan; and.
• ¹¹ Division of Leukemia and Lymphoma, Children's Cancer Center, National Center for Child Health and Development, Tokyo.
• ¹² Department of Pediatrics, Yokohama City University Graduate School of Medicine, Yokohama. [email protected].